These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3348169)

  • 61. [Evaluation of the STA-R analyzer for the study of neonatal and pediatric hemostasis].
    Wu RH; Hurtoud-Roux MF; Boirie M; Schlegel N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):544-7. PubMed ID: 12513718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
    Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies.
    Francis CW; Malone JE; Marder VJ
    Am J Clin Pathol; 1985 Dec; 84(6):724-9. PubMed ID: 4072967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
    Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
    Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the main coagulation tests in the presence of hemolysis in healthy subjects and patients on oral anticoagulant therapy.
    D'Angelo G; Villa C; Tamborini A; Villa S
    Int J Lab Hematol; 2015 Dec; 37(6):819-33. PubMed ID: 26305688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incompatibility of a recombinant thromboplastin and an APTT reagent on a fully automated coagulation analyzer.
    Kappelmayer J; Ajzner E; Muszbek L
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):251-2. PubMed ID: 9199824
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implementation of a microcontroller-based semi-automatic coagulator.
    Chan K; Kirumira A; Elkateeb A
    J Med Eng Technol; 2001; 25(4):143-8. PubMed ID: 11601440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interferences between Clot in the Erythrocyte Sediment and Hemostasis Exploration.
    Delianu C; Moscalu M; Ghizdovat V; Hurjui LL; Hurjui I; Tărniceriu CC; Foia L
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interference of lipemia in samples for routine coagulation testing using a Sysmex CS-5100 coagulometer.
    Negrini D; Bernardi D; Antonelli G; Plebani M
    Int J Lab Hematol; 2019 Dec; 41(6):772-777. PubMed ID: 31508901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests.
    Halbmayer WM; Weigel G; Quehenberger P; Tomasits J; Haushofer AC; Aspoeck G; Loacker L; Schnapka-Koepf M; Goebel G; Griesmacher A
    Clin Chem Lab Med; 2012; 50(9):1601-5. PubMed ID: 23100377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jacquemin M; Jochmans K; Mullier F; Wijns W; China B; Vernelen K; Soumali MR
    Int J Lab Hematol; 2017 Aug; 39(4):402-408. PubMed ID: 28304137
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
    Morishima Y; Kamisato C
    Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Accuracy of coagulation studies performed on blood samples obtained from arterial cannulae.
    Haynes SR; Allardyce W; Cowan B; Tansey P
    Br J Anaesth; 1992 Dec; 69(6):599-601. PubMed ID: 1467103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume.
    Balboni F; Barbui S; Gallo M; Berardi M; Vezzosi M; Lippi G
    Diagnosis (Berl); 2020 Jan; 7(1):55-60. PubMed ID: 31421038
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.